Kolexia
Prevost Jean-Briac Oncologie radiothérapie
Prevost Jean-Briac
Oncologie radiothérapie
Clinique Ambroise Pare
Beuvry, France
60 Activités
12.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinome épidermoïde Carcinomes Carcinome canalaire du sein Carcinome épidermoïde de la tête et du cou Carcinome pulmonaire non à petites cellules Métastase lymphatique Tumeurs du poumon Tumeurs osseuses

Collaborateurs

Voir plus
Fadin Aurelie
Fadin Aurelie
Clinique Ambroise Pare, Beuvry, France
Fares Mustapha
Fares Mustapha
Clinique Ambroise Pare, Beuvry, France
Basson Laurent
Basson Laurent
Cabinet libéral, Arras, France
Ampere Alexandre
Ampere Alexandre
Centre Hospitalier de Bethune, Béthune, France

Industries

Voir plus
MundiPharma
20 collaboration(s)
Dernière en 2023
AstraZeneca
17 collaboration(s)
Dernière en 2023
Sanofi
7 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
TREAT ctDNA: Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse
Essai Clinique (Menarini)   23 janvier 2024
STEREO-OS: Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
Essai Clinique (Unicancer)   11 décembre 2023
NIRVANA-LUNG: PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
Essai Clinique (Unicancer)   11 décembre 2023
QISEIN: Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer - Randomized, Placebo-controlled, Double-blind Study
Essai Clinique (Centre François-Baclesse)   10 novembre 2023
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   02 novembre 2023
935P A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology   28 octobre 2022
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study.
EClinicalMedicine   04 novembre 2020
LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
KALICOU3: Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Essai Clinique (Centre Oscar-Lambret)   24 juin 2019